Mi­cro­cap car­dio play­er touts a 'siz­able' tech deal with Bay­er's Blue­Rock in wake of 'go­ing con­cern' alert

A mi­cro­cap biotech play­er op­er­at­ing un­der a “go­ing con­cern” alert is tout­ing a tie-up with Bay­er’s Blue­Rock, a high-pro­file out­fit ex­plor­ing the fron­tiers of cell ther­a­py R&D.

Sun­ny­vale, CA-based Bio­Car­dia says it nabbed a “siz­able” up­front in the pact, which will put a catheter-based sys­tem it de­vised to de­liv­er a pa­tient’s bone mar­row cells to heart mus­cle to use in Blue­Rock’s car­dio work. Bio­Car­dia re­port­ed it won a break­through de­vice award from the FDA on that.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.